“Multiple sclerosis”的搜索结果，显示 371-380 项，共有 9415 项
Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...
... multiple system atrophy (MSA), progressive supranuclear palsy (PSP), cortico-basal degeneration (CBD), and other even rarer forms of neurodegeneration. A ...
This will speed the pace of medical advancement and treatment recommendations for these conditions. A Study to Analyze Intracerebral Hemorrhage Hematoma.
Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...
Thomas E. Witzig, M.D.. Internist; Oncologist; Hematologist. Rochester, MN. 擅长领域：. Multiple myeloma, Non- ...
... multiple) and stem cell transplant. A Study to Identify Biomarkers in the Blood, Saliva or Tissue for Oropharyngeal Squamous Cell Cancer. Rochester, Minn ...
... Multiple Myeloma (SMM), who are at a High Risk (HR) of developing active multiple myeloma. The aim of this study is to find out whether linvoseltamab is ...
The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple ... Immune Phenotyping in Amyotrophic Lateral Sclerosis.
... multiple converging biomarkers will be necessary to identify the earliest pathological changes, as subtle differences from healthy controls may fall within ...
... multiple system atrophy (MSA), progressive supranuclear palsy (PSP), cortico-basal degeneration (CBD), and other even rarer forms of neurodegeneration.
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。